Oliver Lagore Vanvalin Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.4K | Buy |
+105
| New | +$6.4K | ﹤0.01% | 473 |
|
|
2024
Q4 | $5.94K | Hold |
105
| – | – | ﹤0.01% | 494 |
|
|
2024
Q3 | $5.43K | Hold |
105
| – | – | ﹤0.01% | 498 |
|
|
2024
Q2 | $4.36K | Hold |
105
| – | – | ﹤0.01% | 521 |
|
|
2024
Q1 | $5.69K | Sell |
105
-1
| -0.9% | -$54 | ﹤0.01% | 487 |
|
|
2023
Q4 | $5.42K | Buy |
106
+1
| +1% | +$51 | ﹤0.01% | 500 |
|
|
2023
Q3 | $6.09K | Hold |
105
| – | – | ﹤0.01% | 507 |
|
|
2023
Q2 | $6.72K | Buy |
+105
| New | +$6.72K | ﹤0.01% | 535 |
|
|
2022
Q4 | – | Sell |
-39
| Closed | -$3K | – | 675 |
|
|
2022
Q3 | $3K | Hold |
39
| – | – | ﹤0.01% | 487 |
|
|
2022
Q2 | $3K | Buy |
+39
| New | +$3K | ﹤0.01% | 459 |
|